Tharimmune Inc
THAR
Get informed when a big investor buys or sells
+ FollowMarket Cap$767.7M
Close$
$0.53
85% downside
Current Fair Value
85% downsideOvervalued by 85% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $767.70 Million |
|---|---|
| Enterprise Value | $730.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.12 |
| Beta | 1.45 |
| Outstanding Shares | 216,864,938 |
Return
| Return on Equity | -21.57% |
|---|---|
| Return on Assets | -17.38% |
| Return on Invested Capital | -13.49% |
Valuation & Multiples
| P/E Ratio | -1.34 |
|---|---|
| PEG | -0.14 |
| Price to Sales | - |
| Price to Book Ratio | 1.77 |
| Enterprise Value to Revenue | 488.32 |
| Enterprise Value to EBIT | -9.64 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tharimmune Inc
12 employees
CEO: Mark Wendland Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technolo...